For a drug to be approved for the pregnant population, it must go through rigorous testing with that population, and that has not yet happened for semaglutide or other GLP-1 (glucagon-like peptide 1) agonists, says Carrie Burns , MD, a board-certified endocrinologist and director of diabetes in pregnancy at Penn Medicine in Philadelphia
How Does Novanex Ensure Safety Through COA Verification at 503A Pharmacies
While liraglutide also showed cardiovascular benefit (13% reduction in the LEADER trial), semaglutides evidence is more recent, more robust, and specifically applicable to patients with obesity
(See the blog.) A systematic review found that these drugs might be helpful in intracranial hypertension, a condition that appears to be widespread in these diseases
For joint and tendon concerns, BPC-157 is frequently discussed
doi: 10.1017/S0007114509991747